Secondary osteoporosis and bone quality
Soen, S.
Clinical Calcium 15(6): 965-969
2005
ISSN/ISBN: 0917-5857 PMID: 15930708 Document Number: 584837
In secondary osteoporosis, rheumatoid arthritis patients showed high bone turnover and the same cut-off value in bone mineral density as postmenopausal osteoporosis. On the other hand, Glucocorticoid-induced osteoporosis showed low bone turnover and the higher cut-off value compared with postmenopausal osteoporosis. Examination about secondary osteoporosis except these conditions is needed.
Document emailed within 1 workday
Related Documents
Nakamura, T. 2008: Assessment of bone quality. Drug developments for restoring bone mass and quality in the treatment of osteoporosis Clinical Calcium 18(3): 374-380Li, M.; Saito, T.; Amizuka, N. 2008: Assessment of bone quality. Bone quality of steroid-induced osteoporosis Clinical Calcium 18(3): 328-335
Aujla, K.; Majithia, V. 2016: Assessment of Secondary Causes of Osteoporosis and Racial Differences in Men with Normal vs. Abnormal Bone Mineral Density in a Cohort of Men Undergoing Bone Mass Measurement Journal of the Mississippi State Medical Association 57(9): 285-288
Fukumoto, S. 2018: Secondary osteoporosis. Abnormal bone metabolism in rickets/osteomalacia Clinical Calcium 28(12): 1605-1609
Kishimoto, H. 2005: Antiresorptive therapy for osteoporosis and bone quality Clinical Calcium 15(6): 1007-1011
Varga, O.Iu.; Vezikova, N.N.; Marusenko, I.M.; Kheĭfets, L.M. 2007: Osteogenon in therapy of distal radial bone fractures in patients with secondary osteoporosis Terapevticheskii Arkhiv 79(3): 52-54
Mosekilde, L. 1995: Assessing bone quality--animal models in preclinical osteoporosis research Bone 17(4 Suppl): 343s-352s
Sajdak, S.; Krawczyk, J.; Piatek, J.; Kopczyński, Z. 2000: The applicability of biochemical markers of bone metabolism for predicting the risk of bone fractures and for the assessment of bone tissue resorption in the course of osteoporosis Clinical and Experimental Obstetrics and Gynecology 27(2): 118-120
Scharla, S.H. 1999: Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis MMW Fortschritte der Medizin 141(31-32): 32-36
Yamamoto, N.; Tsuchiya, H. 2017: New methods for the evaluation of bone quality. Bone anabolic agents and bone quality Clinical Calcium 27(8): 1169-1178
Nakatsuka, K.; Nishizawa, Y.; Miura, M. 2006: Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement of PICP and PINP in the evaluation of pharmaceutical treatment efficacy for osteoporosis Clinical Calcium 16(6): 977-985
Rude, R.K.; Kirchen, M.E.; Gruber, H.E.; Meyer, M.H.; Luck, J.S.; Crawford, D.L. 1999: Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption Magnesium Research 12(4): 257-267
Delmas, P.D.; Wahner, H.W.; Mann, K.G.; Riggs, B.L. 1983: Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein Journal of Laboratory and Clinical Medicine 102(4): 470-476
Hasegawa, M.; Ichimura, S.; Satomi, K. 2010: Effects of SERMs on bone health. the evaluation of raloxifene treatment for elderly women with osteoporosis using bone turnover markers Clinical Calcium 20(3): 413-420
Solov'ev, I.N.; Mitin, V.N.; Garanin, D.V.; Frolov, V.I. 1998: Secondary osteosarcoma (in a dog) after bone fracture healed on the secondary type Arkhiv Patologii 60(4): 41-44
Saito, M. 2006: Poor bone quality in diabetes: detrimental collagen cross-link pattern reduces bone strength without change in bone mineral density Clinical Calcium 16(8): 1287-1295
Radspieler, H.; Dambacher, M.A.; Kissling, R.; Neff, M. 2000: Is the amount of trabecular bone-loss dependent on bone mineral Density? a study performed by three centres of osteoporosis using high resolution peripheral quantitative computed tomography European Journal of Medical Research 5(1): 32-39
Sadat-Ali, M.; Al Elq, A.H. 2007: Sickle cell anaemia: is it a cause for secondary osteoporosis? West African Journal of Medicine 26(2): 134-137
Vestergaard, P.; Eiken, P.A. 2005: Secondary osteoporosis, epidemiology and risk factors Ugeskrift for Laeger 167(9): 1020-1026
Yamamoto, M.; Sugimoto, T. 2014: Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis Clinical Calcium 24(9): 1379-1385